Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Cronos Group stock

CRON.TO
CA22717L1013
A2DMQY

Price

2.03
Today +/-
-0.00
Today %
-0.21 %
P

Cronos Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Cronos Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Cronos Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Cronos Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Cronos Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Cronos Group Stock Price History

DateCronos Group Price
11/18/20242.03 undefined
11/15/20242.03 undefined
11/14/20242.08 undefined
11/13/20242.17 undefined
11/12/20242.26 undefined
11/11/20241.95 undefined
11/8/20242.01 undefined
11/7/20242.07 undefined
11/6/20242.07 undefined
11/5/20242.24 undefined
11/4/20242.22 undefined
11/1/20242.16 undefined
10/31/20242.11 undefined
10/30/20242.11 undefined
10/29/20242.21 undefined
10/28/20242.22 undefined
10/25/20242.24 undefined
10/24/20242.20 undefined
10/23/20242.23 undefined
10/22/20242.27 undefined
10/21/20242.15 undefined

Cronos Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cronos Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cronos Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cronos Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cronos Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cronos Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cronos Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cronos Group’s growth potential.

Cronos Group Revenue, EBIT and net profit per share

DateCronos Group RevenueCronos Group EBITCronos Group Net Income
2029e136.7 M undefined0 undefined-23.28 M undefined
2028e131.24 M undefined-37.32 M undefined-27.37 M undefined
2027e135.12 M undefined-28.24 M undefined-27.37 M undefined
2026e131.4 M undefined-40.29 M undefined-70.19 M undefined
2025e132.52 M undefined-33.7 M undefined-16.57 M undefined
2024e113.34 M undefined-21.47 M undefined-42.11 M undefined
202387.24 M undefined-79.91 M undefined-73.96 M undefined
202286.75 M undefined-104.39 M undefined-168.73 M undefined
202174.44 M undefined-196.92 M undefined-396.11 M undefined
202046.72 M undefined-169.66 M undefined-73.14 M undefined
201923.75 M undefined-115.78 M undefined1.17 B undefined
201812.12 M undefined-21.34 M undefined-21.64 M undefined
20173.15 M undefined-10.58 M undefined1.92 M undefined
2016420,000 undefined-3.23 M undefined-900,000 undefined
20150 undefined-1.83 M undefined170,000 undefined
20140 undefined-2.37 M undefined-4.36 M undefined
20130 undefined-20,000 undefined-20,000 undefined
20120 undefined-30,000 undefined-30,000 undefined

Cronos Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
000003122346748687113132131135131136
------300.0091.67100.0060.8716.221.1629.8916.81-0.763.05-2.963.82
------100.0050.00-73.91-54.35-22.9717.4412.649.738.338.408.158.408.09
00000-36-17-25-171511000000
00-0000-0.021.17-0.07-0.4-0.17-0.07-0.04-0.02-0.07-0.03-0.03-0.02
-------2,200.00-5,652.38-106.26442.47-57.58-56.55-42.47-61.90337.50-61.43--14.81
0.390.3932.2443.6978.25176.79172.27342.81351.58370.39376.96380.96000000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The Cronos Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cronos Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
201220132014201520162017201820192020202120222023
                       
000000.010.021.511.2910.880.86
00000.10.93.14.68.922.0723.1113.98
00000.22.72.711.917.111.2314.6621.89
00002.89.77.4384432.837.5630.5
0000.10.40.62.812.612.48.977.115.41
00000.010.020.041.571.371.080.960.93
001.1210.544.7126166.5197.482.9562.8360.82
004.76.45.74.17.92019.7135.1689.7554.74
00000004587.280.6472.3569.04
001.41.28.38.98.271.269.718.0826.721.08
000.30.31.31.41.3214.5179.51.11.031.06
00000000010019345
007.59.925.859.1143.4517.2553.5318.02252.85206.78
000.010.010.030.080.182.091.931.41.211.14
                       
0.10.211.710.72566.4175561.2569.3595.5611.32613.73
000.60.40.5011.323.234.632.4742.6848.45
0-0-0-0-0-0-0.031.141.060.660.490.42
00001.22.5-9.927.84349.87-0.820.68
000000000000
000.010.010.030.070.151.751.711.341.141.1
000.50.80.96.333.235.342.111.2211.1612.13
00000000.41.328.7823.628.73
0000.11.900297.2163.414.3833.360.54
0010080000000000
00003000001.330
000.61.75.86.333.2332.9206.854.3769.4541.4
0000.404.3000000
000.30.11.11.10000.0800
0000000.16.78.57.12.551.56
000.30.51.15.40.16.78.57.182.551.56
000.92.26.911.733.3339.6215.361.5571.9942.96
000.010.010.030.080.182.091.931.41.221.14
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Cronos Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cronos Group's financial health and stability.

Assets

Cronos Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cronos Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cronos Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cronos Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20122013null2014201520162017201820192020202120222023
000-0000-0.021.17-0.08-0.4-0.17-0.07
000000013715138
0000000000000
00000-3-43-54-33-220-26
0002-10-28-1,245-402304650
0000000000000
00000000000033
000-1-1-4-4-7-130-142-153-88-42
000-1-1-1-32-88-38-35-12-5-2
000-6-1-6-29-93-60320-28-1-59
000-50-43-5-56455-163-56
0000000000000
00000-3011-16-2000
0000.0100.020.040.121.880000
0000.0100.010.040.121.86-0.01-0.01-0-0
----1.00---2.00-7.00-4.00-3.00-13.00-2.00-1.00
0000000000000
00000000.021.18-0.12-0.19-0.12-0.1
-0.0300-2.52-2.26-6.04-37.19-96.11-169.22-177.85-165.88-93.98-45.34
0000000000000

Cronos Group stock margins

The Cronos Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cronos Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cronos Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cronos Group's sales revenue. A higher gross margin percentage indicates that the Cronos Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cronos Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cronos Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cronos Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cronos Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cronos Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cronos Group Margin History

Cronos Group Gross marginCronos Group Profit marginCronos Group EBIT marginCronos Group Profit margin
2029e13.65 %0 %-17.03 %
2028e13.65 %-28.43 %-20.86 %
2027e13.65 %-20.9 %-20.26 %
2026e13.65 %-30.66 %-53.42 %
2025e13.65 %-25.43 %-12.51 %
2024e13.65 %-18.94 %-37.16 %
202313.65 %-91.6 %-84.78 %
202217.79 %-120.34 %-194.51 %
2021-23.56 %-264.55 %-532.15 %
2020-55.29 %-363.14 %-156.55 %
2019-74.11 %-487.49 %4,911.62 %
201851.24 %-176.07 %-178.55 %
2017-107.3 %-335.87 %60.95 %
2016-33.33 %-769.05 %-214.29 %
201513.65 %0 %0 %
201413.65 %0 %0 %
201313.65 %0 %0 %
201213.65 %0 %0 %

Cronos Group Stock Sales Revenue, EBIT, Earnings per Share

The Cronos Group earnings per share therefore indicates how much revenue Cronos Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cronos Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cronos Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cronos Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cronos Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cronos Group Revenue, EBIT and net profit per share

DateCronos Group Sales per ShareCronos Group EBIT per shareCronos Group Earnings per Share
2029e0.36 undefined0 undefined-0.06 undefined
2028e0.34 undefined0 undefined-0.07 undefined
2027e0.35 undefined0 undefined-0.07 undefined
2026e0.34 undefined0 undefined-0.18 undefined
2025e0.35 undefined0 undefined-0.04 undefined
2024e0.3 undefined0 undefined-0.11 undefined
20230.23 undefined-0.21 undefined-0.19 undefined
20220.23 undefined-0.28 undefined-0.45 undefined
20210.2 undefined-0.53 undefined-1.07 undefined
20200.13 undefined-0.48 undefined-0.21 undefined
20190.07 undefined-0.34 undefined3.4 undefined
20180.07 undefined-0.12 undefined-0.13 undefined
20170.02 undefined-0.06 undefined0.01 undefined
20160.01 undefined-0.04 undefined-0.01 undefined
20150 undefined-0.04 undefined0 undefined
20140 undefined-0.07 undefined-0.14 undefined
20130 undefined-0.05 undefined-0.05 undefined
20120 undefined-0.08 undefined-0.08 undefined

Cronos Group business model

Cronos Group Inc is a Canadian company specializing in the production and distribution of medical and recreational cannabis. It was founded in 2013 and is headquartered in Toronto, Canada. Cronos Group Inc is one of the leading cannabis producers in Canada and has also made a name for itself in the international market. History Cronos Group Inc started as a medical cannabis startup focused on the cultivation and production of high-quality cannabis products for the medical market. In 2016, the company was listed on the Toronto Stock Exchange and raised 40 million Canadian dollars through a capital increase. In 2018, it received a $1.8 billion investment from Altria Group Inc, one of the world's largest tobacco companies. This investment helped Cronos grow and establish itself in the global cannabis market. Business model Cronos Group Inc has a diversified business model focusing on the production, processing, and marketing of cannabis products. The company specializes in the cultivation and production of high-quality cannabis products suitable for both the medical and recreational markets. Cronos Group Inc also produces cannabis oils, vaporizer pens, and other smoke-free products. The various subsidiaries Cronos Group Inc consists of several subsidiary companies focusing on different aspects of the cannabis industry. Some of the key subsidiaries of Cronos Group Inc are: 1. Peace Naturals - This company specializes in the cultivation of medical cannabis and also produces cannabis oils and vaporizable products. 2. Original BC - Original BC is a leading provider of recreational cannabis, offering a wide range of cannabis products. 3. Sublime Culture - Sublime Culture specializes in the production of cannabis extracts and the development of novel cannabis products like THC-infused gummy bears. Products Cronos Group Inc offers a wide range of cannabis products suitable for both the medical and recreational markets. Some of the key products of Cronos Group Inc include: 1. Cannabis oils - The company produces a wide range of cannabis oils suitable for medical and recreational use. 2. Vaporizer pens - Cronos Group Inc also produces vaporizable products for smoke-free consumption of cannabis products. 3. Edibles - The company also offers a range of novel cannabis products like THC-infused gummy bears, contributing to the growth of the market. Conclusion Cronos Group Inc is one of the leading cannabis companies worldwide specializing in the production and distribution of medical and recreational cannabis. The company has made a name for itself with its wide range of cannabis products and has grown and established itself in the international market through the investment from Altria Group Inc. Cronos Group Inc has implemented a diversified business model, offering medical cannabis, recreational cannabis, and novel cannabis products to grow in the increasing demand and provide its customers with a wide range of offerings. Cronos Group is one of the most popular companies on Eulerpool.com.

Cronos Group SWOT Analysis

Strengths

1. Strong brand reputation and market presence: Cronos Group Inc has established itself as a leading player in the cannabis industry, both in Canada and globally.

2. Solid financial position: The company has sufficient financial resources, enabling it to invest in research and development, expand production capacities, and pursue strategic partnerships.

3. Diverse product portfolio: Cronos Group offers a wide range of cannabis products, including dried flower, oils, and vaporizers, catering to different consumer preferences and market segments.

Weaknesses

1. Regulatory challenges: The cannabis industry operates under strict regulations, which may result in uncertainties and constraints for Cronos Group, especially in international markets.

2. Limited production capacity: Despite ongoing expansions, the company's production capacity may not be sufficient to meet the growing demand for cannabis products, potentially hindering market share growth.

3. Higher product prices: Cronos Group's premium positioning and focus on quality may result in comparatively higher prices, making its products less affordable for price-sensitive consumers.

Opportunities

1. Legalization and market expansion: Increasing legalization of cannabis across different jurisdictions presents opportunities for Cronos Group to penetrate new markets and drive sales growth.

2. Expansion of product offerings: The company can diversify its product portfolio further by introducing innovative cannabis-based products, such as edibles, beverages, and cosmetics, to tap into evolving consumer trends.

3. Strategic partnerships: Collaborating with established companies in related industries, such as pharmaceuticals or consumer goods, can provide Cronos Group with access to new distribution channels and enhance market reach.

Threats

1. Competitive market landscape: The cannabis industry is becoming increasingly competitive, with the presence of both established players and new entrants, posing challenges for Cronos Group to maintain its market share and pricing power.

2. Legal and regulatory risks: Changes in laws and regulations, both domestically and internationally, regarding the production, distribution, or use of cannabis can impact the company's operations and profitability.

3. Negative social perception: Despite ongoing efforts to normalize the use of cannabis, societal stigma surrounding marijuana consumption may hinder widespread acceptance and limit the market potential for Cronos Group's products.

Cronos Group Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Cronos Group Revenue by Segment

Segmente2023202220212020
Cannabis flower62.07 M USD63.59 M USD55.19 M USD27.93 M USD
Cannabis extracts24.57 M USD27.68 M USD18.68 M USD18.25 M USD
Other602,000 USD634,000 USD560,000 USD533,000 USD

Cronos Group Revenue by Region

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Cronos Group Revenue by Segment

DateCanadaIsraelOther countriesUnited States
202364.7 M USD21.13 M USD1.41 M USD-
202256.23 M USD30.52 M USD-5.16 M USD
202150.29 M USD13.38 M USD891,000 USD9.87 M USD
202034.54 M USD-2.69 M USD9.5 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Cronos Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Cronos Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Cronos Group shares outstanding

The number of shares was Cronos Group in 2023 — This indicates how many shares 380.965 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cronos Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cronos Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cronos Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cronos Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cronos Group stock splits

In Cronos Group's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Cronos Group.

Cronos Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2024-0.01 -0.02  (-96.08 %)2024 Q3
6/30/2024-0 -0.02  (-669.23 %)2024 Q2
3/31/2024-0.02 -0.01  (34.64 %)2024 Q1
12/31/2023-0.02 -0.05  (-145.1 %)2023 Q4
9/30/2023-0.02 0  (100 %)2023 Q3
6/30/2023-0.03 -0.01  (68.35 %)2023 Q2
3/31/2023-0.04 -0.05  (-15.21 %)2023 Q1
12/31/2022-0.05 -0.21  (-296.23 %)2022 Q4
9/30/2022-0.06 -0.1  (-73.31 %)2022 Q3
6/30/2022-0.06 -0.05  (12.43 %)2022 Q2
1
2
3
4

Eulerpool ESG Scorecard© for the Cronos Group stock

Eulerpool World ESG Rating (EESG©)

32/ 100

🌱 Environment

5

👫 Social

66

🏛️ Governance

25

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Cronos Group shareholders

%
Name
Stocks
Change
Date
40.95621 % Altria Group Inc156,573,53704/25/2024
2.64126 % Gorenstein (Michael Ryan)10,097,416253,6193/31/2024
2.56901 % Adler (Jason Marc)9,821,183-59,5873/31/2024
2.07961 % Chescapmanager, L.L.C.7,950,237-376,8536/30/2024
1.86743 % The Vanguard Group, Inc.7,139,09487,3446/30/2024
1.44603 % ETF Managers Group, LLC5,528,0915,528,0913/31/2023
1.25982 % Tidal Investments LLC4,816,226-1,780,2316/30/2024
1.18260 % Gotham Green Partners, LLC4,521,026503,3203/31/2024
0.68842 % Dimensional Fund Advisors, L.P.2,631,783192,4696/30/2024
0.65419 % Two Sigma Investments, LP2,500,954778,5526/30/2024
1
2
3
4
5
...
10

Cronos Group Executives and Management Board

Mr. Michael Gorenstein(36)
Cronos Group Executive Chairman of the Board, President, Chief Executive Officer (since 2016)
Compensation 17.59 M
Mr. Jeffrey Jacobson(37)
Cronos Group Chief Growth Officer
Compensation 1.19 M
Ms. Anna Shlimak(37)
Cronos Group Senior Vice President, Corporate Affairs and Strategy
Compensation 800,505
Mr. Ran Gorelik(62)
Cronos Group General Manager, Cronos Israel
Compensation 687,369
Mr. James Holm(40)
Cronos Group Chief Financial Officer
Compensation 614,307
1
2
3
4

Cronos Group Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
LVMH Moet Hennessy Louis Vuitton Stock
LVMH Moet Hennessy Louis Vuitton
SupplierCustomer0,25-0,45-0,440,40-0,02-0,32
MediPharm Labs Stock
MediPharm Labs
SupplierCustomer0,08-0,530,590,680,970,47
Altria Group Stock
Altria Group
SupplierCustomer0,080,22-0,42-0,80-0,41-0,42
urban-gro Stock
urban-gro
SupplierCustomer-0,16-0,460,560,550,41
1

Most common questions regarding Cronos Group

What values and corporate philosophy does Cronos Group represent?

Cronos Group Inc represents core values of integrity, innovation, and responsibility. As a leading global cannabinoid company, Cronos Group is committed to providing innovative and high-quality products to its customers. The company's corporate philosophy revolves around transparency, sustainability, and community partnerships. Cronos Group focuses on advancing cannabinoid research, developing industry-leading intellectual property, and driving the growth of the cannabis industry. With a commitment to regulatory compliance and ethical practices, Cronos Group Inc prioritizes the well-being and satisfaction of their stakeholders while promoting the benefits of cannabinoid-based therapies.

In which countries and regions is Cronos Group primarily present?

Cronos Group Inc is primarily present in Canada and the United States.

What significant milestones has the company Cronos Group achieved?

Cronos Group Inc has achieved several significant milestones. The company became the first cannabis producer to be listed on a major stock exchange in 2018, trading on the NASDAQ under the ticker symbol CRON. Additionally, Cronos Group Inc expanded its global presence by entering strategic partnerships and acquisitions in various countries. These include a joint venture in Israel, a supply and distribution agreement in Germany, and a partnership in Australia. Furthermore, the company has focused on research and development initiatives to innovate and develop novel cannabinoid-based products. Cronos Group Inc continues to make strides in the cannabis industry, positioning itself for further growth and success.

What is the history and background of the company Cronos Group?

Cronos Group Inc, a leading Canadian cannabis company, has a rich history and background. Founded in 2013, it quickly established itself as a pioneer in the cannabis industry. The company operates globally and focuses on developing and distributing high-quality cannabis products. Cronos Group Inc has successfully formed partnerships with renowned brands, such as Marlboro-maker Altria Group, enhancing its market position. With a commitment to innovation and sustainability, Cronos prides itself on its diverse portfolio of brands and a strong research and development team. As a market leader, Cronos Group Inc continues to shape the future of the cannabis industry with its dedication to excellence and commitment to delivering shareholder value.

Who are the main competitors of Cronos Group in the market?

The main competitors of Cronos Group Inc in the market are Canopy Growth Corporation, Aurora Cannabis Inc, and Tilray Inc.

In which industries is Cronos Group primarily active?

Cronos Group Inc is primarily active in the cannabis industry.

What is the business model of Cronos Group?

The business model of Cronos Group Inc. revolves around the cultivation, production, and distribution of cannabis and cannabis-derived products worldwide. As a leader in the cannabis industry, Cronos Group focuses on developing and building iconic brands, partnering with retail networks, and expanding distribution channels. By prioritizing innovation and research, Cronos Group aims to provide high-quality and differentiated cannabis products to its diverse customer base. With a strategic global presence and a commitment to sustainability, Cronos Group Inc. strives to drive industry growth and shape the future of cannabis.

What is the P/E ratio of Cronos Group 2024?

The Cronos Group P/E ratio is -18.32.

What is the P/S ratio of Cronos Group 2024?

The Cronos Group P/S ratio is 6.81.

What is the Quality Investing of Cronos Group?

The Quality Investing for Cronos Group is 4/10.

What is the revenue of Cronos Group 2024?

The expected Cronos Group revenue is 113.34 M USD.

How high is the profit of Cronos Group 2024?

The expected Cronos Group profit is -42.11 M USD.

What is the business model of Cronos Group

The Cronos Group Inc is a Canadian company that operates in the manufacturing and marketing of cannabis products. Cronos' business model is based on vertical integration, allowing the company to complete all steps from cultivation to sales under one roof. One of Cronos' core divisions is cannabis cultivation. The company operates its own cultivation areas in Canada and other countries, equipped with the latest technology and highest standards. Through outdoor and indoor cultivation, Cronos can offer a wide range of cannabis varieties that cater to individual customer needs. Another important aspect of Cronos is the production of cannabis extracts and derivatives. The company utilizes its own cultivation areas and processes the harvested material into high-quality products such as oils, tinctures, capsules, and vapes. The broad portfolio of cannabis derivatives allows Cronos to target different market segments and cover a wide range of applications. In addition to production, Cronos also offers comprehensive consulting services. Experienced consultants and experts are available to assist customers in selecting the right product and individual dosage. This builds trust and customer satisfaction and strengthens the company's image as a responsible cannabis provider. Cronos markets its products through various channels, including its own online shop, retailers, and wholesalers. The company has been particularly successful in international marketing. Cronos collaborates with partners in different countries to position its products in the global market. The company focuses on a high-quality brand strategy and clear positioning as a premium provider. In addition to the mentioned business areas, Cronos also invests in research and development. This is aimed at strengthening the company's position as an innovation leader in the cannabis industry and exploring new applications. One focus is on the medical use of cannabis derivatives, which have shown positive effects in numerous medical conditions. Overall, Cronos' business model is characterized by a clear strategy, professional management, and a broad portfolio of high-quality products. Successful international marketing and positioning as a premium provider contribute significantly to the company's success. Investments in research and development will continue to support Cronos in offering innovative products and expanding its market position.

What is the Cronos Group dividend?

Cronos Group pays a dividend of 0 USD distributed over payouts per year.

How often does Cronos Group pay dividends?

The dividend cannot currently be calculated for Cronos Group or the company does not pay out a dividend.

What is the Cronos Group ISIN?

The ISIN of Cronos Group is CA22717L1013.

What is the Cronos Group WKN?

The WKN of Cronos Group is A2DMQY.

What is the Cronos Group ticker?

The ticker of Cronos Group is CRON.TO.

How much dividend does Cronos Group pay?

Over the past 12 months, Cronos Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cronos Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Cronos Group?

The current dividend yield of Cronos Group is .

When does Cronos Group pay dividends?

Cronos Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cronos Group?

Cronos Group paid dividends every year for the past 0 years.

What is the dividend of Cronos Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cronos Group located?

Cronos Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cronos Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cronos Group from 11/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Cronos Group pay the last dividend?

The last dividend was paid out on 11/18/2024.

What was the dividend of Cronos Group in the year 2023?

In the year 2023, Cronos Group distributed 0 USD as dividends.

In which currency does Cronos Group pay out the dividend?

The dividends of Cronos Group are distributed in USD.

All fundamentals about Cronos Group

Our stock analysis for Cronos Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cronos Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.